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Background: Tanzania adopted Intermittent-preventive treatment of malaria in pregnancy (IPTp) policy in 2000; the
guidelines at the time of the study recommended the timing of the first dose of intermittent preventive treatment
in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) (IPTp-SP) at 20–24 weeks and the timing of the second
dose at 28–32 weeks. The aim of this study was to identify factors that are responsible for the uptake of IPTp
among pregnant Tanzanian women. Further, this study aims to justify the need for appropriate interventions that
would strengthen the Tanzanian IPTp program towards the realization of the Roll Back Malaria (RBM) targets.
Methods: Data were analyzed from the 2011–2012 Tanzania HIV and Malaria Indicators Survey (THMIS) of 1,616
women aged 15–49 years who had a live birth in the 2 years prior to the survey and received antenatal care (ANC)
services.
Results: Logistic regression analysis results showed that (1) being in the age groups 30–34 and 35–39 versus other
age groups and being married or living with partner versus those who reported as never married or divorced/
separated were associated with high uptake of IPTp; (2) women pregnant with their first or second child versus
those who already have had two or more children had higher odds of completing the recommended number of
IPTp dosage; and (3) being a resident from the Eastern Zone versus Lake Zone as well as having the first antenatal
visit in the first or second trimester versus third trimester were associated with higher uptake of IPTp.
Conclusion: Applying these results could contribute to positive social change by helping providers, clinics, and
organizations seeking to increase IPTp uptake among ANC attendees and providing health education programs to
women, especially those residing in rural areas. This study could also help achieve United Nations Millennium
Development Goals (MDG) 6 (combat HIV/AIDS, Malaria and Other Diseases).
Keywords: Malaria, Pregnancy, Intermittent preventive treatment of malaria in pregnancy, Sulfadoxine-
pyrimethamine, TanzaniaBackground
Malaria, a mosquito-borne illness, which is preventable
and treatable, is a major public health concern. In 2013,
97 countries had ongoing malaria transmission. An esti-
mated 3.4 billion people are at risk for malaria. In 2012,
there were an estimated 207 million cases of malaria and
an estimated 627,000 deaths. 90 % of all malaria deaths
occur in sub-Saharan Africa. In 2012, malaria killed an
estimated 482,000 children under five years of age. That* Correspondence: skibusi@gmail.com
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creativecommons.org/publicdomain/zero/1.0/is 1,300 children every day, or one child almost every
minute. Between 2000 and 2012, the increase in malaria
interventions helped to reduce malaria incidence rates
by 25 % globally, and by 31 % in the World Health
Organization (WHO) African Region. Additionally, the
global malaria mortality rate was reduced by 42 % dur-
ing the same period, and the decrease in the malaria
mortality rate in the WHO African Region was 49 %.
During this same time period, increased malaria inter-
ventions saved an estimated 3.3 million lives. 90 %, or 3
million of these, are in the under-five age group in sub-
Saharan Africa [1].icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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in 2010, 2011, and 2012 were 1,278,998; 2,150,761; and
1,986,955, respectively. The number of reported deaths
from malaria in 2010, 2011, and 2012 were 15,867; 11,806;
and 7,820 respectively [2]. Although the number of deaths
from malaria has decreased (which is thought to be due to
the increase in malaria interventions), Tanzania still has a
high burden of malaria disease and each year many people
become infected with the disease.
Malaria infection during pregnancy is also a major
public health concern and poses many risks and threats
to the mother, her unborn fetus, and the newborn. Mater-
nal illness and low birth weight due to malaria are likely
the result of Plasmodium falciparum infection, which oc-
curs predominantly in Africa. Infection with P. falciparum
can lead to chronic anemia, placental malaria infection,
and low birth weight, all of which increase the risk of neo-
natal death [3]. Recommendations for the treatment and
prevention of malaria during pregnancy include the
following: (1) use of long-lasting insecticidal nets (LLINs);
(2) intermittent preventive treatment in pregnancy (IPTp)
with sulfadoxine-pyrimethamine (SP) in areas of stable
malaria transmission of sub-Saharan Africa; and (3)
prompt diagnosis and effective treatment of malaria
infections [3].
Given the health risks that malaria infection during
pregnancy poses to the mother, her unborn fetus, and the
newborn, adequate measures should be taken to treat and
prevent malaria infection during pregnancy. Intermittent
preventive treatment of malaria in pregnancy (IPTp) is a
full course of therapeutic antimalarial medicine given to
pregnant women at routine prenatal visits. The antimalar-
ial medicine is given to the mothers regardless of whether
they are infected with malaria. IPTp helps to reduce mater-
nal malaria episodes, maternal and fetal anemia, placental
parasitemia, low birth weight, and neonatal mortality [4].
Current recommendations from WHO for IPTp include
administration of sulfadoxine-pyrimethamine (SP) to preg-
nant women at each scheduled antenatal care (ANC)
visit, starting as early as possible in the second tri-
mester, provided that the doses are given at least one
month apart. SP should not be given during the first tri-
mester of pregnancy. WHO recommends a schedule of
at least four ANC visits during pregnancy [5]. Tanzania’s
current IPTp-SP guidelines are reflective of the current
WHO recommendations.
Persistent, high levels of SP resistance markers have been
identified in Tanzania by researchers who conducted a
cross-sectional survey of six different regions in Tanzania
[6]. Additionally, the rapid spread of SP resistance led
Tanzania to replace SP therapy with artemisinin-based
combinational therapy (ACT) in 2006 [7]. Due to safety
concerns for ACT use during pregnancy, SP continues to
be used in IPTp [6]. Given the importance of IPTp-SP inprevention of malaria in pregnancy and its resulting out-
comes, such as maternal illness and low birth weight,
WHO continues to recommend IPTp-SP use [4].
According to WHO, among the approximately 780
million persons at risk for contracting malaria in en-
demic countries in sub-Saharan Africa, an estimated 32
million pregnant women could benefit from IPTp each
year. However, in the last few years, declining efforts to
scale-up IPTp in several African countries has been ob-
served [4]. Of importance is the fact that IPTp noticeably
lags behind other malaria control measures in high-
burden countries. Low levels of antenatal clinic attend-
ance do not appear to be a contributing factor; however,
uncertainty among health workers about SP administra-
tion may play a role [4].
Florey [8] analyzed demographic health surveys (DHS)
in Sub-Saharan African countries in an effort to identify
factors contributing to decreased IPTp delivery and
found that IPTp was effectively delivered for only 18 %
of targeted women. 83 % of women attended an antenatal
clinic (ANC) at least once and 97 % of women who re-
ceived one dose of SP attended an ANC twice. Therefore,
access to ANC service was not found to be a major reason
for the low rate of IPTp delivery. The study did, however,
find that IPTp delivery is inadequate in these countries.
Number and timing of ANC visits, type of health facility,
and malaria transmission risk were identified as important
predictors of IPTp delivery [8].
Another study found that in 31 countries with IPTp pol-
icies, 19 million pregnant women were unprotected by
IPTp. This same study found that low coverage with inter-
mittent preventive treatment contrasted with high ANC
attendance which suggests that there are missed oppor-
tunities when women attend clinics but are not given
intermittent preventive treatment [9]. Several other stud-
ies have investigated factors affecting uptake of and access
to intermittent preventive treatment. These studies identi-
fied unclear messages about IPTp (specifically, timing of
doses), limited supply of SP, limited understanding of
IPTp, late enrollment or irregular ANC visits, and nurse
underachievement as factors contributing to decreased
uptake of intermittent preventive treatment [10-14].
The aim of this study is to identify the factors associ-
ated with the uptake of IPTp among pregnant women in
Tanzania and to justify the need for appropriate inter-
ventions that will strengthen the Tanzania IPTp program




Cross-sectional survey of nationally representative sam-
ple of individuals aged 15–49 years living in Tanzania in
the period between December 2011 and May 2012.
All women N=10,967 
(Weighted) 
Women with a live birth 2 years 
prior to the survey N=3,555 
(Weighted)
Women with live birth 2yrs prior 
to the survey and attended ANC 
N= 1,615 (Weighted) 
Fig. 1 Sample selection
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The study was based on data from the 2011/12 Tanzania
HIV and Malaria Indicators Survey (THMIS), conducted
by the National Bureau of Statistics (NBS) in collaboration
with the Tanzania Commission for AIDS (TACAIDS) and
the Zanzibar AIDS Commission (ZAC), the Ministry of
Health and Social Welfare (MoHSW) and the USAID-
funded MEASURE DHS project from December 16, 2011,
to May 24, 2012.
The sampling frame used for the 2011–12 THMIS was
developed by the National Bureau of Statistics (NBS) after
the 2002 Population and Housing Census (PHC) which
covered all of the 30 regions of Tanzania. The sampling
frame excluded nomadic and institutional populations such
as persons in hotels, barracks, and prisons. The sample was
selected in two stages. The first stage involved selecting
sample points (clusters) consisting of enumeration areas
(EAs) delineated for the 2002 PHC. A total of 583 clusters
were selected. On the Mainland, 30 sample points were se-
lected in Dar es Salaam and 20 were selected in each of the
other 24 regions. In Zanzibar, 15 sample points were selected
in each of the five regions. The second stage of selection in-
volved the systemic sampling of households. A household
listing operation was undertaken in all the selected areas
prior to the fieldwork. From these lists, households to be
included in the survey were selected. Approximately 18
households were selected from each sample point for a
total sample size of 10,496 households. Weighting factors
were added to the data file so that the results will be pro-
portional at the national level. All women and men age
15–49 who were either permanent residents of the se-
lected households or visitors who stayed in the household
the night before the survey were eligible to be interviewed.
Questionnaire
Two questionnaires were used for the 2011–12 THMIS:
the Household Questionnaire and the Individual Question-
naire. These questionnaires are based on the MEASURE
DHS standard AIDS Indicator Survey and Malaria Indicator
Survey questionnaires and were adapted to reflect the popu-
lation and health issues relevant to Tanzania. The ques-
tionnaires were translated into Kiswahili; the national
language of Tanzania. Data presented in this study is based
on the individual questionnaire.
Completed interviews were obtained for 10,967 women,
yielding a response rate of 96 %. Of the 9,388 eligible men
identified, 8,352 were successfully interviewed (89 % re-
sponse rate). The principal reason for non-response among
both eligible women and men was the failure to find them
at home despite repeated visits to the households.
Sample selection
Questions regarding malaria in pregnancy were adminis-
tered to women who have had a pregnancy in the past 5years before the survey. To control recall bias we selected
3,555 women with a live birth 2 years prior to the survey
out of the 10,967 women who completed the interviews.
IPTp uptake was verified on the antenatal card, therefore
only women with a live birth in the past 2 years and who
attended antenatal services were included.
Out of the 3,555 women, 1,809 were excluded with 1,746
women remaining who had their antenatal cards at the
time of survey as a proof of antenatal care attendance dur-
ing pregnancy. Further, 130 women were excluded for lack
of information about uptake of IPTp remaining with a
sample of 1,616 women who were included in this study
(Fig. 1).
Variables
Guided by literature review, useful variables were identified
from the 2011–12 THMIS Individual questionnaire. A con-
ceptual framework was developed comprised of a list of
primary independent variables (such as socio-economic and
demographic variables), modifiable variable/intermediate in-
dependent variables, which are variables that could po-
tentially be affected by the primary independent variables
(such as number and timing of antenatal visits as well as
birth under professional assistance) and lastly the outcome
variable.
Outcome measures
Uptake of IPTp was the outcome variable of interest de-
fined as uptake of the recommended two or more doses
of IPTp; one during the second trimester and the second
during the third trimester (WHO, 2003). Women who
did not take or took less than the recommended number
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Independent variables
This study included several socioeconomic and demo-
graphic variables that have been theoretically and empiric-
ally linked to malaria in pregnancy and uptake of IPTp.
Participants’ age was categorized as follows: 15–24, 25–34,
and 35–49 years of age. The participant’s area of residence
was categorized as being rural or urban. The education
level of women was categorized as follows; no education,
primary incomplete, primary complete and secondary or
higher education. We categorized a woman’s marital sta-
tus into never married, separated/widowed and married.
Occupation was categorized as unemployed, self employed
and employed. Participant’s wealth index was categorized
as follows: poorest, poorer, middle income, richer and
richest. The wealth index is constructed using household
asset data, including ownership of consumer items ran-
ging from a television to a bicycle or car, as well as dwell-
ing characteristics, such as source of drinking water,
sanitation facilities, and type of flooring material. The
wealth index was created in three steps. In the first step, a
subset of indicators common to urban and rural areas was
used to create wealth scores for households in both areas.
In the second step, separate factor scores were produced
for households in urban and rural areas using area-
specific indicators. The third step combined the separate
area-specific factor scores to produce a nationally applic-
able combined wealth index by adjusting area-specific
scores through a regression on the common factor scores.
The resulting combined wealth index has a mean of zero
and a standard deviation of one. Wealth quintiles (from
lowest to highest) were formed by assigning the household
score to each participant, ranking each person in the study
by that score, and then dividing the ranking into the
five wealth index quintiles. We included parity defined
as a woman’s number of live births that were categorized
as: no child, 1 child, 2 children, and 3+ children. We fur-
ther categorized Tanzania into nine zones, which tend
to have different seasons and malaria prevalence. The
zones included Eastern, Western, Southern, Southern High,
South West Highlands, Central, Northern, Lake and the
Zanzibar zone.
We also included intermediate factors potentially re-
lated to the uptake of IPTp and malaria in pregnancy.
We categorized access to information about malaria
whether a woman ever heard or never heard about IPTp
(yes or no). We assessed access to antenatal services by
including two variables; timing of the 1st Antenatal visit
and the source of anti-malarias during the most recent
pregnancy prior to the survey. Participant’s timing of the
1st Antenatal visit was categorized as being in; 1st tri-
mester, 2nd trimester or 3rd trimester. Source of anti-malarias was categorized as antenatal centers or other
sources.
Statistical analyses
We calculated descriptive statistics for sample’s socio-
demographic characteristics and IPTp uptake. Chi-square
test was used to assess socio-demographic differences in
IPTp uptake. The level of significance was set at P < 0.05
(2-tailed) for all the analyses. Both bivariate and multiple
logistic regression were used to generate crude (OR) and
adjusted odds ratios (AOR). Odds ratios were estimated to
assess the strength of the associations and used the 95 %
confidence intervals (CIs) for significance testing. All the
covariates which showed statistically significant relation-
ship (P < 0.05) with the outcome variable after Chi-square
test were entered simultaneously into the multiple regres-
sion model. Analyses were performed using SPSS version
16. Sample weighting was applied to allow for adjustments
for the cluster sampling design and sampling probabilities
across clusters and strata.
Ethical considerations
Data collection procedures for the THMIS were approved
by Tanzania’s National Institute for Medical Research
(NIMR), the Zanzibar Medical Ethics and Research Com-
mittee (ZAMREC), the Institutional Review Board of ICF
International, and the Centers for Disease Control and Pre-
vention in Atlanta. The protocol of the survey was reviewed
and approved by the Tanzania’s National Institute for
Medical Research (NIMR), the Zanzibar Medical Ethics
and Research Committee (ZAMREC), the Institutional
Review Board of ICF International, and the Centers for
Disease Control and Prevention in Atlanta. All the partici-
pants were asked to provide verbal informed consent after
being read a document emphasizing the voluntary nature
of the survey. Interviews were conducted under the most
private conditions afforded by the environments encoun-
tered. If privacy could not be ensured, the interviewers
were instructed to skip the module.
Results
Table 1 shows the distribution of participants by socio-
demographic characteristics and uptake of IPTp. Most of
the participants have completed at least primary education.
There was a significant relationship (p < 0.001) between
education level and uptake of IPTp with the highest per-
centage of those with no education (75 %) having reported
low uptake. Participants in the age groups 30–34 and
35–39 years were proportionally more likely to complete
uptake of IPTp than those in other age groups (uptake at
42 and 40 % respectively) (p < .01). Uptake was lower
among participants who were self-employed (30.4 %) than
other occupational groups (p < .001).
Table 2 Distribution of participants by uptake of IPTp and the
potential factors affecting uptake (Chi-Square)
Variable % of women who took IPTp P-value
<2 doses 2+ doses
n % n %
Wealth Index
Poorest 212 72.4 81 27.6
Poorer 249 66.4 126 33.6
Middle 233 71.7 92 28.3 ***
Richer 223 68.0 105 32.0
Richest 146 49.8 147 50.2
Zones
Eastern 99 44.8 122 55.2 ***
Western 97 67.4 47 32.6
Southern 34 57.6 25 42.4
S Highlands 99 57.6 73 42.4
SW Highlands 108 70.1 46 29.9
Central 106 69.3 47 30.7
Northern 74 59.2 51 40.8
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tential factors which may affect uptake of IPTp. Distri-
bution of participants by wealth, showed higher uptake
of IPTp among the richest group (50.2) and much lower
uptake among the poorest whom only 28 % reported to
have completed the recommended 2+ doses (<0.001).
Comparing participants’ uptake levels by reported number
of children (parity); around 58 % of those with no children
took the recommended number of dosages; the highest
among all groups (p < 0.001). Surprisingly, mothers with
three or more children had the lowest uptake (around
24 % only took the recommended number of dosages).
Timing of the first visit to an antenatal clinic where IPTp
services are provided had a significant relationship to
completion of uptake of IPTp (p < 0.001) with participants
making their first visit during the third trimester having
the lowest level of uptake. Only 18 % of women making
their first visit during the third trimester completed 2 or
more doses as compared to 44 % of those who started
their visit right on time in the first trimester.
There was significant variation in terms of uptake of
IPTp by the region in Tanzania where a participant residesTable 1 The distribution of participants by socio-demographic
characteristics and uptake of IPTp
Variables % of women who took IPTp P-value
<2 doses 2+ doses
n % n %
Education
No education 233 75.2 77 24.8
Primary inco 127 68.3 59 31.7 ***
Primary comp. 599 64.5 330 35.5
Secondary+ 104 54.7 86 45.3
Age groups
15–19 157 74.4 54 25.6
20–24 294 68.5 135 31.5
25–29 263 66.1 135 33.9 **
30–34 164 60.1 109 39.9
35–39 127 57.7 93 42.3
40–44 52 70.3 22 29.7
45–49 7 63.6 4 36.4
Occupation
Unemployed 127 58.3 91 41.7
Self employed 748 69.6 327 30.4 ***
Employed 187 58.3 134 41.7
Marital Status
Never married 90 62.5 54 37.5
Divorced/Separated 80 72.1 31 27.9
Married 893 65.6 468 34.4
Here *, ** and *** indicate p < 0.05, p < 0.01 and p< 0.001 respectively. N= 1616.
Participants missing some information on independent variables: 2 on occupation
Lake 411 77.3 121 22.7
Zanzibar 36 64.3 20 35.7
Parity
No child 11 42.3 15 57.7
One child 315 58.9 220 41.1 ***
Two Children 397 65.3 211 34.7
3+ Children 340 76.4 105 23.6
1st ANC Visit ***
1st trimester 149 55.8 118 44.2
2nd trimester 733 65.1 393 34.9
3rd trimester 182 81.6 41 18.4
Ever heard about IPTp
Yes 555 60.0 370 40.0
No 508 73.5 183 26.5 ***
Dose Source
Antenatal visit 498 50.3 492 49.7 ***
Other source 566 90.4 60 9.6
Here *, ** and *** indicate p < 0.05, p < 0.01 and p < 0.001 respectively. N = 1616.
Participants missing some information on independent variables: 2 on wealth & 2
on parity(P < 0.001). Proportionally, participants from the Eastern,
Sothern and Southern highlands had higher uptake com-
pared with regions like the Lake Zone where uptake was
around 23 % only.
Awareness about malaria prevention programs was high
and significantly related to uptake of IPTp (p < 0.001) with
those reporting to have ever heard about IPTp recording
higher uptake than those who didn’t (40 % versus 27 %).
Source of anti-malarial medications during pregnancy was
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pants who received anti-malarial medications during ante-
natal visits reported higher uptake (50 %) compared with
only 10 % among those who received the medications
from other sources.
The results of logistic regression analysis presented in
Table 3 below, indicate that being in the age groups 30–
34 and 35–39 years, being married or living with a part-
ner, were associated with higher uptake of IPTp control-
ling for other factors. Logistic regression analysis also
showed that women at first or second pregnancy had
higher odds of completing the recommended number ofTable 3 Adjusted Odds Ratios (AOR) for factors associated with
uptake of IPTp among women who attended ANC services and
had a live birth 2 years before the survey (N = 1616)





30–34 1.88 1.16–6.05 **





Never married 1.29 0.08–2.08
Divorced/Separated 0.61 0.37–1.01 *
Zones
Eastern 1
Western 0.82 0.49–1.38 ***
Southern 0.63 0.32–1.22 **
Southern Highlands 0.81 0.50–1.31
Southern West Highlands 0.44 0.27–0.73
Central 0.51 0.30–0.85
Northern 0.68 0.41–1.13
Lake 0.54 0.35–0.83 **
Zanzibar 0.46 0.23–0.93 *
Parity
Three or more Children No child 1
One child 3.08 1.21–7.83 *
Two Children 1.42 1.00–2.02 *
1.10 0.80–1.51
Timing of 1st ANC Visit:
3rd trimester 1
1st trimester 1.99 1.24–3.21 **
2nd trimester 1.94 1.29–2.90 ***
Here *, ** and *** indicate p < 0.05, p < 0.01 and p < 0.001 respectivelyIPTp dosage than those who already have had two or
more children. Being a resident from the Eastern Zone
as well as having the first antenatal visit in the first or
second trimester was associated with higher uptake of
IPTp.
Discussion
The aim of this study was to identify factors that are respon-
sible for the uptake of IPTp among pregnant Tanzanian
women. Further, we hoped to justify the need for appropri-
ate interventions that would strengthen Tanzanian IPTp
programs towards the realization of the Roll Back Malaria
(RBM) targets. The result of this study support the con-
ceptual framework that guided this study, that is, uptake
of IPTp is related to demographic factors (i.e., age, resi-
dence [rural/urban], education level, marital status, occu-
pation, wealth index, parity, and geographical zones) and
intermediate factors, which include access to information
and access to services.
There was a significant relationship between uptake of
IPTp and participants’ level of education, age, occupation,
wealth, parity, and region of participants’ residence. Partic-
ipants with no or low education level, young participants,
self-employed participants, low-income participants, and
participants with three or more children reported low up-
take of IPTp. Uptake of IPTp was lowest in the Lake Zone
region. There are several factors that contribute to the low
uptake of IPTp among pregnant women. Researchers in
Nigeria from Akinleye, Falade & Ajayi [15] found that IPTp
use among pregnant women was very low and there was
poor adherence despite utilization of Directly Observed
Therapy (DOT). Based on our results we support the need
for a concerted effort to increase awareness of IPTp among
the public especially women of child bearing age [15]. Fur-
ther, Ouma et al. [17] found that there was confusion
about appropriate timing and lack of direct observation of
IPTp in Kenya. Combined with our findings, we would
support the need to train health workers on how to moni-
tor IPTp adherence and also to communicate the import-
ance of uptake of IPTp using simplified messages.
The timing of the first visit to an antenatal clinic where
IPTp services are provided had a significant relationship
to completion of uptake of IPTp with participants making
their first visit during the third trimester having the lowest
level of uptake. Tanzania’s national IPTp guidelines at the
time of the study was that the timing of the first dose
IPTp-SP was at 20–24 weeks and the timing of the second
dose was at 28–32 weeks of pregnancy. This may lead to
missed opportunities as most women attend ANC during
or before the fourth month of gestation. In Tanzania, Anders,
Marchant, Chambo, Mapunda & Reyburn [16] found that
almost half the participants first attended ANC during or
before the fourth month of gestation; however, 86 % of
these early attendees did not receive IPTp on their first
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ities, SP was out of stock. We support the need to review
national guidelines for when to start SP as efforts to en-
courage earlier attendance at ANC alone are unlikely to
improve uptake of IPTp.
Awareness about malaria prevention programs was
high and significantly related to uptake of IPTp with
those reporting to have ever heard about IPTp recording
higher uptake than those who did not. The source of
anti-malarial medications during pregnancy also signifi-
cantly related to IPTp uptake. Participants who received
anti-malarial medications during antenatal visits reported
higher uptake (50 %) compared with only 10 % among
those who received the medications from other sources.
In another Tanzanian study, Mubyazi, Bloch, Kamugisha,
Kitua & Ijumba [14] found that pregnant women and
ANC staff were generally aware of SP as the drug recom-
mended for IPTp; however, some nurses and pregnant
women expressed concerns about the safety of the drug
during pregnancy. Further, Mubyazi [14] reported that
compliance with taking SP was low especially when
women were allowed to take the drug at home. Mubyazi
[14] noted that compliance of direct observed therapy in
administering SP for IPTp at ANC clinics was an issue
due to shortage of clean water and cups. We support the
need for proper planning of, support of, and training of
health care workers and sustained sensitization of preg-
nant women at health facility and community levels about
the benefits of IPTp for the women and their fetuses.
This study had the following limitations. First, the re-
searchers only examined women who had a live birth in the
past two years. This study did not include women whose
children died before birth or were still born. Second, the
primary source of the information collected from the re-
search participants was self-report. Recall bias could influ-
ence the final reported information. Recall bias may result
in underestimation or overestimation of past experiences or
events. Third, we were limited on the variables that were
available in the DHS questionnaire; thus, we could not ex-
plore other factors that could be relevant for this study, for
example, beliefs/perception/attitude of the participants
and their partners towards IPTp. Finally, the study did not
address issues of stockpiling and availability of SP doses.
There is a possibility that women who attended ANC per
recommended guidelines failed to receive the medication
because the medications were not available.
Recommendations for future research include qualita-
tive studies to provide a much deeper understanding of
the factors that contribute to uptake and adherence of
IPTp. We recommend that future researchers explore is-
sues of stock piling, provider’s beliefs, women and their
partners’ beliefs, and the influence on women by their
partners and the extended family at large related to up-
take and adherence of IPTp.Conclusion
Tanzania adopted IPTp policy in 2000; the guidelines at
the time of the study were that the timing of the first
dose IPTp-SP was at 20–24 weeks and the timing of the
second dose was at 28–32 weeks. Findings of this study
could help providers, clinics, and organizations seeking
to increase IPTp uptake among ANC attendees and pro-
viding health education programs to women especially
those residing in rural areas. Applying these study re-
sults could also help achieve United Nations Millennium
Development Goals (MDG) 6 (combat HIV/AIDS, Malaria
and Other Diseases). We found that women who came
late to ANC have low uptake of IPTp and this could
indicate that the women who came late to ANC are also
likely to miss other interventions embedded in ANC ser-
vices, e.g. prevention of mother-to-child HIV transmis-
sion (PMTCT). This study also highlights the women
who are at a high risk of missing IPTp services in Tanzania,
e.g. women from the Lake Zone region and young women;
therefore, future interventions should focus on these
groups. Policy implications for this study include address-
ing low uptake of IPTp with the focus being on young
mothers aged 15–19 years. Policy should also address
the issue of women making their first ANC visit dur-
ing the third trimester, thus contributing to low uptake
of IPTp. Further, policy should support the linkage of
IPTp and ANC because utilization of ANC increases up-
take of IPTp.
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